![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, September 09, 2019 12:01:35 PM
Real numbers --- Nivida trades at 9x sales and it is growing sales at like 20%/year. Sona is much smaller and is growing sales at 100%/year.
Even if we were to trade at NVDA's multiple we would be at a 9x15M (sales) which is 135M Market cap, or about 5.5x higher than where we are here, which is roughly 77 cents.
Of course, most investors would give Sona a far higher multiple because of its small size and fast sales growth pace. No reason this wouldnt trade at 15-20x sales which of course would be 1.50+.
Of note, this is the OTC and there are about 7 of us here that are retailers, the rest are insiders that buy and hold and not few others know about this, so this wont trade at a normal valuation until this moves to a higher exchange IMO and/or gets some legit big money accredited investors involved.
We are currently trading at 1.8x sales.
FEATURED Mawson Finland Provides Update on Exploration Activities at Rajapalot • Aug 21, 2024 9:06 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM